Skip to search formSkip to main contentSkip to account menu

Trifluperidol

Known as: 1-Butanone, 1-(4-fluorophenyl)-4-(4-hydroxy-4-(3-(trifluoromethyl)phenyl)-1-piperidinyl)-, Trifluperidol [Chemical/Ingredient] 
A butyrophenone with general properties similar to those of HALOPERIDOL. It is used in the treatment of PSYCHOSES including MANIA and SCHIZOPHRENIA… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
The neurotoxic side effects observed for the neuroleptic agent haloperidol have been associated with its pyridinium metabolite… 
2004
2004
SummaryThe effects of trifluperidol (20 to 80 μg/kg), haloperidol (40 to 160μg/ kg) and caffeine (10 mg/kg) on a fixed-ratio… 
1986
1986
Although it is essential that intraocular pressure (IOP) be reduced in glaucoma treatment, it is also vitally important to… 
1977
1977
Trifluperidol (TFP), at a concentration of 100 muM, inhibited the 24-h growth of Saccharomyces cerevisiae by about 30%. Effects… 
1971
1971
1968
1968
Trifluperidol, a butyrophenone compound with antipsychotic properties, was studied for its behavioral and hypocholesterolemic… 
1963
1963
Under double-blind conditions, the effects of trifluperidol, one of the butyrophenone derivatives, were contrasted with the…